Integrated Clinical Systems, Inc. Opens European Branch Office in Switzerland
Integrated Clinical Systems, Inc. announced the opening of a European branch office in Switzerland
Integrated Clinical Systems, Inc. (ICS) www.i-review.com, developers of Integrated Review™ & JReview®, the world’s most comprehensive clinical review and analysis software tool, today announced the opening of a European branch office in Switzerland. The office will be the company’s first location in Europe, dedicated to client management and business development in Europe, Middle East & Africa (EMEA).
ICS’s EMEA branch office is located in Lausanne, Switzerland. It will be led by Dr. Mark Demesmaeker, Director of EMEA & Asia Operations, who joined the company in January from TIBCO Spotfire where he headed the clinical analytics practice.
Eric S. Herbel, President of ICS said, “Our European customers have been frequently asking for an ICS regional presence and support. As a consequence, we have decided to set up a European branch office in order to better serve our European customers and also expand our footprint in the EMEA region.”
“About 40% of our customer base is located in Europe and the business is constantly growing” says Dr. Demesmaeker. “Many of our clients are global corporations with regional headquarters. Expanding and scaling a high-quality customer service and business development team is a key driver to our continued success in the market.”
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
